BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 469150)

  • 21. Use of progestogen therapy.
    Gambrell RD
    Am J Obstet Gynecol; 1987 May; 156(5):1304-13. PubMed ID: 3578452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Oestrogens as a cause of endometrial carcinoma.
    Corcoran R; Howard R
    Br Med J; 1976 May; 1(6020):1276-7. PubMed ID: 1268664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen use in postmenopausal women.
    Kaunitz AM
    N Engl J Med; 1980 Dec; 303(25):1477-8. PubMed ID: 7432409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contraceptive Steroids, age, and the cardiovascular system.
    Plunkett ER
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
    King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
    J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen replacement therapy and endometrial cancer: the elusive link.
    Maggio M
    J Nurse Midwifery; 1980; 25(2):19-21. PubMed ID: 6898648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrastructural effects of estrogen replacement on postmenopausal endometrium.
    Aycock NR; Jollie WP
    Am J Obstet Gynecol; 1979 Oct; 135(4):461-6. PubMed ID: 573552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The estrogen--cancer controversy.
    Greenblatt RB; Stoddard LD
    J Am Geriatr Soc; 1978 Jan; 26(1):1-8. PubMed ID: 618948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progestogen potency in oral contraceptive pills.
    Gillmer MD
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1048-52. PubMed ID: 3118717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.
    Gambrell RD; Maier RC; Sanders BI
    Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous estrogens and endometrial cancer.
    Gordan GS; Greenberg BG
    Postgrad Med; 1976 Jun; 59(6):66-77. PubMed ID: 778818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal dose combined hormonal replacement therapy for menopausal women.
    Wren BG
    Med J Aust; 1981 Apr; 1(7):353-6. PubMed ID: 7242418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.